A Case for Norepinephrine versus Octreotide and Midodrine in Hepatorenal Syndrome

被引：0
|
作者：
Anong, John [1 ]
Litchfield, John [2 ]
Reddy, Chakradhar [2 ]
Borthwick, Thomas [2 ]
机构：
[1] E Tennessee State Univ, Dept Internal Med, Johnson City, TN 37614 USA
[2] E Tennessee State Univ, Dept Gastroenterol, Johnson City, TN 37614 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2013年 / 108卷
关键词：
D O I：
10.14309/00000434-201310001-00402
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
402
引用
收藏
页码：S120 / S120
页数：1
相关论文
共 50 条
  • [1] TERLIPRESSIN VERSUS MIDODRINE/OCTREOTIDE FOR HEPATORENAL SYNDROME
    Juang, Paul
    Yeary, Julianne
    Barker, Skyler
    Owen, Emily
    CRITICAL CARE MEDICINE, 2025, 53 (01)
  • [2] TREATMENT OF HEPATORENAL SYNDROME WITH OCTREOTIDE ALBUMIN AND MIDODRINE
    Jain, Akhil
    Hunsicker, Lawrence G.
    Voigt, Michael D.
    HEPATOLOGY, 2008, 48 (04) : 1086A - 1086A
  • [3] Noradrenalin Versus the Combination of Midodrine and Octreotide in Patients with Hepatorenal Syndrome: Randomized Clinical Trial
    Tavakkoli, Hamid
    Yazdanpanah, Kambiz
    Mansourian, Marjan
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2012, 3 (11) : 764 - 769
  • [4] EVALUATION AND OUTCOMES OF MIDODRINE, OCTREOTIDE, AND ALBUMIN IN PATIENTS WITH HEPATORENAL SYNDROME
    Patel, Jignesh
    Tran, Michelle
    Trujillo, Nalea
    Mata, Kenneth
    Chan, Patrick
    CRITICAL CARE MEDICINE, 2024, 52
  • [5] Terlipressin is superior to midodrine/octreotide for hepatorenal syndrome type 1
    Kalambokis, Georgios N.
    Baltayiannis, Gerasimos
    Christodoulou, Dimitrios
    Christou, Leonidas
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (12) : 1428 - 1429
  • [6] Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide
    Angeli, P
    Volpin, R
    Gerunda, G
    Craighero, R
    Rone, P
    Merenda, R
    Amodio, P
    Sticca, A
    Caregaro, L
    Maffei-Faccioli, A
    Gatta, A
    HEPATOLOGY, 1999, 29 (06) : 1690 - 1697
  • [7] Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial
    Cavallin, Marta
    Kamath, Patrick S.
    Merli, Manuela
    Fasolato, Silvano
    Toniutto, Pierluigi
    Salerno, Francesco
    Bernardi, Mauro
    Romanelli, Roberto Giulio
    Colletta, Cosimo
    Salinas, Freddy
    Di Giacomo, Antonio
    Ridola, Lorenzo
    Fornasiere, Ezio
    Caraceni, Paolo
    Morando, Filippo
    Piano, Salvatore
    Gatta, Angelo
    Angeli, Paolo
    HEPATOLOGY, 2015, 62 (02) : 567 - 574
  • [8] Octreotide, midodrine, and albumin, triple therapy is effective in reversing Hepatorenal Syndrome.
    Hassanein, TI
    Abdeen, O
    El-Tahawy, M
    Hart, M
    Khanna, A
    Mehta, R
    HEPATOLOGY, 2001, 34 (04) : 542A - 542A
  • [9] Standardized approach of albumin, midodrine and octreotide on hepatorenal syndrome treatment response rate
    Hiruy, Aklil
    Nelson, Joelle
    Zori, Andreas
    Morelli, Giuseppe
    Cabrera, Roniel
    Kamel, Amir
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (01) : 102 - 106
  • [10] Does Midodrine and Octreotide Truly Improve Survival in Cirrhotic Patients with Hepatorenal Syndrome?
    Gonzalez, Humberto
    Sharma, Rishi
    Huang, Mary Ann
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S154 - S154
12345